TY - JOUR
T1 - Admission blood pressure and clinical outcomes in patients with acute ischaemic stroke treated with intravenous alteplase and endovascular treatment versus endovascular treatment alone
T2 - A MR CLEAN-NO IV substudy
AU - van den Berg, Sophie A.
AU - Venema, Simone M. Uniken
AU - LeCouffe, Natalie E.
AU - Postma, Alida A.
AU - Nijeholt, Geert J. Lycklama A.
AU - Rinkel, Leon A.
AU - Treurniet, Kilian M.
AU - Kappelhof, Manon
AU - Bruggeman, Agnetha E.
AU - van Kranendonk, Katinka R.
AU - Majoie, Charles B. L. M.
AU - Dippel, Diederik W. J.
AU - van der Worp, H. Bart
AU - Coutinho, Jonathan M.
AU - Nederkoorn, Paul J.
AU - Roos, Yvo B. W. E. M.
AU - MR CLEAN-NO IV Investigators
PY - 2023/9
Y1 - 2023/9
N2 - Introduction: High systolic blood pressure ( SBP) is associated with poor functional outcome. We analysed whether the association of SBP with outcomes after endovascular treatment (EVT) is modified by prior intravenous thrombolysis (IVT).Patients and methods: This was a post-hoc analysis of MR CLEAN-NO IV, a randomised trial of IVT with alteplase followed by EVT versus EVT alone, within 4.5 h from stroke onset. SBP was recorded on hospital admission. The primary outcome was 90-day modified Rankin Scale (mRS) score and secondary outcomes included symptomatic intracranial haemorrhage (sICH) and successful reperfusion (eTICI 2b-3), analysed with (ordinal) logistic regression. Estimates were calculated per 10 mmHg change in SBP. We assessed whether IVT modified the associations of SBP with these outcomes using multiplicative interaction terms.Results: Of 539 randomised patients, 266 received IVT. The association of SBP with mRS score was J-shaped, with an inflection point at 150 mmHg. Using 150 mmHg as a reference point, SBPs higher than 150 mmHg were associated with poor functional outcome (acOR: 1.23, 95% CI: 1.09-1.38), but lower SBPs were not (acOR: 1.14, 95% CI: 0.99-1.30). Higher SBP was not associated with the risk of sICH (aOR: 1.09, 95% CI: 0.93-1.27) nor with the probability of successful reperfusion (aOR: 1.00, 95% CI: 0.91-1.10). Our main result was that we found no effect modification by IVT (p-values for interaction, mRS = 0.94; sICH = 0.26; successful reperfusion = 0.58).Discussion and conclusion: There was no effect modification of IVT with SBP for any of the clinical outcomes. Therefore, the level of SBP (if.185/110 mmHg) should not guide IVT decisions in patients otherwise eligible for both IVT and EVT within the 4.5-h time window.Trial registration: ISRCTN80619088, https://www.isrctn.com/ISRCTN80619088.
AB - Introduction: High systolic blood pressure ( SBP) is associated with poor functional outcome. We analysed whether the association of SBP with outcomes after endovascular treatment (EVT) is modified by prior intravenous thrombolysis (IVT).Patients and methods: This was a post-hoc analysis of MR CLEAN-NO IV, a randomised trial of IVT with alteplase followed by EVT versus EVT alone, within 4.5 h from stroke onset. SBP was recorded on hospital admission. The primary outcome was 90-day modified Rankin Scale (mRS) score and secondary outcomes included symptomatic intracranial haemorrhage (sICH) and successful reperfusion (eTICI 2b-3), analysed with (ordinal) logistic regression. Estimates were calculated per 10 mmHg change in SBP. We assessed whether IVT modified the associations of SBP with these outcomes using multiplicative interaction terms.Results: Of 539 randomised patients, 266 received IVT. The association of SBP with mRS score was J-shaped, with an inflection point at 150 mmHg. Using 150 mmHg as a reference point, SBPs higher than 150 mmHg were associated with poor functional outcome (acOR: 1.23, 95% CI: 1.09-1.38), but lower SBPs were not (acOR: 1.14, 95% CI: 0.99-1.30). Higher SBP was not associated with the risk of sICH (aOR: 1.09, 95% CI: 0.93-1.27) nor with the probability of successful reperfusion (aOR: 1.00, 95% CI: 0.91-1.10). Our main result was that we found no effect modification by IVT (p-values for interaction, mRS = 0.94; sICH = 0.26; successful reperfusion = 0.58).Discussion and conclusion: There was no effect modification of IVT with SBP for any of the clinical outcomes. Therefore, the level of SBP (if.185/110 mmHg) should not guide IVT decisions in patients otherwise eligible for both IVT and EVT within the 4.5-h time window.Trial registration: ISRCTN80619088, https://www.isrctn.com/ISRCTN80619088.
KW - Blood pressure
KW - hypertension
KW - endovascular treatment
KW - intravenous thrombolysis
KW - acute ischaemic stroke
KW - thrombectomy
KW - alteplase
KW - randomised controlled trial
KW - TRIAL
U2 - 10.1177/23969873231173274
DO - 10.1177/23969873231173274
M3 - Article
SN - 2396-9873
VL - 8
SP - 647
EP - 654
JO - European Stroke Journal
JF - European Stroke Journal
IS - 3
ER -